BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8286742)

  • 1. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees.
    van der Poll T; Levi M; van Deventer SJ; ten Cate H; Haagmans BL; Biemond BJ; Büller HR; Hack CE; ten Cate JW
    Blood; 1994 Jan; 83(2):446-51. PubMed ID: 8286742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees.
    van der Poll T; Levi M; Hack CE; ten Cate H; van Deventer SJ; Eerenberg AJ; de Groot ER; Jansen J; Gallati H; Büller HR
    J Exp Med; 1994 Apr; 179(4):1253-9. PubMed ID: 8145042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.
    Kuipers B; van der Poll T; Levi M; van Deventer SJ; ten Cate H; Imai Y; Hack CE; ten Cate JW
    J Immunol; 1994 Mar; 152(5):2438-46. PubMed ID: 8133055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.
    Levi M; ten Cate H; Bauer KA; van der Poll T; Edgington TS; Büller HR; van Deventer SJ; Hack CE; ten Cate JW; Rosenberg RD
    J Clin Invest; 1994 Jan; 93(1):114-20. PubMed ID: 8282778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of anti-cytokine treatment on bronchoalveolar hemostasis in endotoxemic chimpanzees.
    Levi M; van Der POLL T; ten CATE H; Kuipers B; Biemond BJ; Jansen HM; ten CATE JW
    Am J Respir Crit Care Med; 1998 Jul; 158(1):92-8. PubMed ID: 9655712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of postponed treatment with an anti-tumour necrosis factor (TNF) F(ab')2 fragment on endotoxin-induced cytokine and neutrophil responses in chimpanzees.
    van der Poll T; Levi M; ten Cate H; Jansen J; Biemond BJ; Haagmans BL; Eerenberg A; van Deventer SJ; Hack CE; ten Cate JW
    Clin Exp Immunol; 1995 Apr; 100(1):21-5. PubMed ID: 7697917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans.
    van der Poll T; Coyle SM; Levi M; Jansen PM; Dentener M; Barbosa K; Buurman WA; Hack CE; ten Cate JW; Agosti JM; Lowry SF
    Blood; 1997 May; 89(10):3727-34. PubMed ID: 9160678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades.
    Biemond BJ; Levi M; Ten Cate H; Van der Poll T; Büller HR; Hack CE; Ten Cate JW
    Clin Sci (Lond); 1995 May; 88(5):587-94. PubMed ID: 7614818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees.
    van Leenen D; van der Poll T; Levi M; ten Cate H; van Deventer SJ; Hack CE; Aarden LA; ten Cate JW
    J Immunol; 1993 Aug; 151(4):2318-25. PubMed ID: 8345209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees.
    van der Poll T; Jansen J; Levi M; ten Cate H; ten Cate JW; van Deventer SJ
    J Exp Med; 1994 Nov; 180(5):1985-8. PubMed ID: 7964475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody to tumor necrosis factor--alpha prevents lethal endotoxin sepsis in adult rhesus monkeys.
    Fiedler VB; Loof I; Sander E; Voehringer V; Galanos C; Fournel MA
    J Lab Clin Med; 1992 Oct; 120(4):574-88. PubMed ID: 1402333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor is involved in the appearance of interleukin-1 receptor antagonist in endotoxemia.
    van der Poll T; van Deventer SJ; ten Cate H; Levi M; ten Cate JW
    J Infect Dis; 1994 Mar; 169(3):665-7. PubMed ID: 8158047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways.
    van Deventer SJ; Büller HR; ten Cate JW; Aarden LA; Hack CE; Sturk A
    Blood; 1990 Dec; 76(12):2520-6. PubMed ID: 2124934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIa.
    Biemond BJ; Levi M; ten Cate H; Soule HR; Morris LD; Foster DL; Bogowitz CA; van der Poll T; Büller HR; ten Cate JW
    Thromb Haemost; 1995 Feb; 73(2):223-30. PubMed ID: 7792734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase.
    Jansen PM; Pixley RA; Brouwer M; de Jong IW; Chang AC; Hack CE; Taylor FB; Colman RW
    Blood; 1996 Mar; 87(6):2337-44. PubMed ID: 8630396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the release of soluble tumor necrosis factor receptors in experimental endotoxemia by an anti-tumor necrosis factor-alpha antibody.
    Jansen J; van der Poll T; Levi M; ten Cate H; Gallati H; ten Cate JW; van Deventer SJ
    J Clin Immunol; 1995 Jan; 15(1):45-50. PubMed ID: 7759600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia.
    Stegenga ME; van der Crabben SN; Blümer RM; Levi M; Meijers JC; Serlie MJ; Tanck MW; Sauerwein HP; van der Poll T
    Blood; 2008 Jul; 112(1):82-9. PubMed ID: 18316629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia.
    Derhaschnig U; Bergmair D; Marsik C; Schlifke I; Wijdenes J; Jilma B
    Crit Care Med; 2004 May; 32(5):1136-40. PubMed ID: 15190963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial and vascular adrenergic alterations in a rat model of endotoxin shock: reversal by an anti-tumor necrosis factor-alpha monoclonal antibody.
    Boillot A; Massol J; Maupoil V; Grelier R; Bernard B; Capellier G; Berthelot A; Barale F
    Crit Care Med; 1997 Mar; 25(3):504-11. PubMed ID: 9118669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant nematode anticoagulant protein c2, a novel inhibitor of tissue factor-factor VIIa activity, abrogates endotoxin-induced coagulation in chimpanzees.
    Moons AH; Peters RJ; Cate Ht; Bauer KA; Vlasuk GP; Büller HR; Levi M
    Thromb Haemost; 2002 Oct; 88(4):627-31. PubMed ID: 12362234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.